je.st
news
Tag: gilead
Premarket Biotech Digest: My Response, Gilead In 2016, Blow For Vivus
2015-12-31 17:25:58| Biotech - Topix.net
Firstly here is the MBBS degree attached. I also have an MD and a PhD . I am traveling in Europe, but if necessary, I will upload those once I return.
Tags: response
blow
digest
biotech
Cloud Of Uncertainty Has Been Covering Gilead Over The Past Year But That's Not Bad
2015-12-30 17:25:33| Biotech - Topix.net
Biotech stocks have been doing relatively well in the past week as depicted by the iShares NASDAQ Biotechnology ETF increasing to the tune of 3.5% but shares of Gilead have not echoed that move upwards. If we even broaden our view of the ETF versus Gilead to the past year, we see that Gilead is down 0.7% while the IBB is up 11.9%.
Will Gilead Turn The Corner In 2016?
2015-12-29 09:17:59| Biotech - Topix.net
Few stocks have frustrated investors more than biotech juggernaut Gilead Sciences in 2015. Despite seeing earnings growth north of 50% year-over-year the stock has not done much this year.
Gilead: The Sign Of Things To Come?
2015-12-22 15:02:14| Biotech - Topix.net
Biotech juggernaut Gilead Sciences has sat out the huge M&A wave that has swept over the biotech & pharma sectors over the past few years. As such the company has seen substantial speculation on what it should buy given its fast growing free cash flow and need to expand its pipeline.
Premarket Biotech Digest: Tracking Gilead HCV Sales, Shire-Baxalta Deal, AstraZeneca Deal
2015-12-17 17:08:44| Biotech - Topix.net
The current consensus forecast for fourth quarter HCV sales is $2.81 billion. In the third quarter, U.S. HCV sales had totaled $3.23 billion.
Tags: sales
deal
tracking
digest
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] next »